Penumbra (PEN) Operating Income Growth (3y) (2017 - 2026)
Penumbra (PEN) Operating Income Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.80 Bn | 176.50 Bn | 6.27 Bn | -3.76% |
| 2 | Stryker | 128.84 Bn | 125.96 Bn | 3.81 Bn | 8.39% |
| 3 | Medtronic | 108.59 Bn | 99.37 Bn | 6.41 Bn | 6.17% |
| 4 | Boston Scientific | 68.51 Bn | 67.06 Bn | 3.61 Bn | 25.88% |
| 5 | Edwards Lifesciences | 48.18 Bn | 44.51 Bn | 1.29 Bn | 7.13% |
| 6 | Dexcom | 28.40 Bn | 27.28 Bn | 750.30 Mn | 75.54% |
| 7 | GE HealthCare Technologies | 28.16 Bn | 25.88 Bn | 1.98 Bn | -2.70% |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 24.66 Bn | 21.54 Bn | 2.07 Bn | 34.83% |
| 10 | Penumbra | 12.58 Bn | 11.96 Bn | 253.41 Mn | 68.39% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 68.39% |
| Dec 31, 2025 | 130.56% |
| Sep 30, 2025 | 107.91% |
| Jun 30, 2025 | 566.24% |
| Mar 31, 2025 | 128.77% |
| Dec 31, 2024 | 45.30% |
| Sep 30, 2024 | 59.10% |
| Jun 30, 2024 | -114.37% |
| Mar 31, 2024 | -3.49% |
| Dec 31, 2023 | 180.52% |
| Sep 30, 2023 | 37.97% |
| Jun 30, 2023 | 44.44% |
| Mar 31, 2023 | 135.90% |
| Dec 31, 2022 | -22.98% |
| Sep 30, 2022 | -25.18% |
| Jun 30, 2022 | -26.22% |
| Mar 31, 2022 | -33.19% |
| Dec 31, 2021 | -100.05% |
| Sep 30, 2021 | 34.28% |
| Jun 30, 2021 | 3.57% |